Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an

Other illness

• Stroke patients caused by brain tumor, brain trauma and blood diseases;
• Those with a history of stroke and sequelae affecting the outcome assessment, namely, mRS 2 points before the onset of this stroke;
• Suffering from other serious life-threatening diseases with an expected survival time of less than 3 months;
• Other diseases that limit neurological function evaluation or affect patient follow-up;

Lab values

• Patients with severe hepatic and renal insufficiency (Note: Hepatic insufficiency refers to ALT or AST values greater than 2 times the upper normal limit; Renal insufficiency refers to blood creatinine value greater than 2 times the normal upper limit);

Other

• Patients who refuse to receive intravenous thrombolysis or intravascular intervention (including intravascular mechanical thrombolysis and arterial thrombolysis);
• Combined with claudication osteoarthritis rheumatoid arthritis gout arthritis and other limb dysfunction and affect the neurological function examination;
• A woman planning to be pregnant or breastfeeding;
• Currently participating in other clinical trials;
• Refuse to participate in the registration of investigators

• 18 years old;
• Consistent with the diagnosis of acute ischemic stroke;
• 24 hours from onset to enrollment;
• Informed consent